(MENAFN- Baystreet) Agilent Gains on Dilution System
Brown-Forman Strikes Deal in Japan, Shares Slump
Cognition to Host Virtual KOL in Mid-April
Monday's Stock Movers
UPS Becomes Air Cargo Provider For The U.S. Postal Service Previous Articles Subscribe to Get Small Cap News & Alerts Glenn Wilkins - Monday, April 1, 2024
Prenetics Flat on
financial Results
Prenetics Global Limited (NASDAQ: PRE) shares began the day, week, month and quarter on the plus side. The Hong Kong-based genomics-driven health sciences company announced unaudited financial results for the fourth quarter and full year ended December 31, 2023, along with recent business updates.
Revenue from continuing operations of US$21.7 million in the full year 2023, an increase of 65.2% as compared to the full year 2022. Revenue from continuing operations of US$5.4 million in the fourth quarter 2023, an increase of 90.8% as compared to the fourth quarter 2022.
Adjusted EBITDA from continuing operations was US$(24.8) million in the full year 2023. Adjusted EBITDA from continuing operations were US$(6.2) million in the fourth quarter 2023.
Cash and other short-term assets of US$93.7 million as of December 31, 2023. Additionally, Insighta, our 50/50 joint venture in early cancer detection with Professor Dennis Lo, had a cash balance of US$79.1 million in its balance sheet as of December 31, 2023.
“This past year,” read this morning's news release,“also marked the completion of a pivotal 500-person clinical trial with Insighta, our early cancer detection venture with Prof. Dennis Lo, yielding very positive results. We expect to publish these findings towards the end of 2024, and we are gearing up for an even more extensive overseas clinical trial beginning in Q3 of this year. Details of this will be shared in the next earnings update.”
PRE shares gained seven cents, or 1.7%, to $4.12.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN01042024000212011056ID1108044213
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.